CVI
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
CVI Accepts, published online ahead of print on 26 March 2008
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
CVI.00438-07v1
15/5/843    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Google Scholar
Right arrow Articles by Herbst, L. H.
Right arrow Articles by Lenz, J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Herbst, L. H.
Right arrow Articles by Lenz, J.

 Previous Article  |  Next Article 

Clin. Vaccine Immunol. doi:10.1128/CVI.00438-07
Copyright (c) 2008, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

ELISA detection of plasma antibodies to baculovirus-expressed glycoprotein H of chelonid FP-associated herpesvirus and its relationship to the prevalence of fibropapillomatosis in sea turtles

Lawrence H. Herbst*, Shefali Lemaire, Ada R. Ene, David J. Heslin, Llewellyn M. Ehrhart, Dean A. Bagley, Paul A Klein, and Jack Lenz

Departments of Pathology, Microbiology and Immunology, and Molecular Genetics, Albert Einstein College of Medicine, Bronx, NY 10461; Department of Biology, University of Central Florida, Orlando, FL; Department of Pathology and Laboratory Medicine, University of Florida, Gainesville, FL

* To whom correspondence should be addressed. Email: herbst{at}aecom.yu.edu.


   Abstract

Chelonid FP-associated herpesvirus (CFPHV) is an alphaherpesvirus believed to cause marine turtle fibropapillomatiosis (FP). A serodiagnostic assay was developed for monitoring sea turtle populations for CFPHV exposure. CFPHV glycoprotein H (gH) expressed in recombinant baculovirus was used in an enzyme-linked immunosorbant assay (ELISA) to detect virus specific 7S turtle antibodies. Using captive-reared green turtles (Chelonia mydas) with no history of virus exposure as "known negatives" and others with experimentally induced FP as "known positives", the assay had 100% specificity but low sensitivity, as seroconversion was detected in only half of the turtles bearing experimentally induced tumors. Antibodies were detected only in samples collected after cutaneous fibropapillomas appeared, consistent with observations that tumors are significant sites of virion production and antigen expression, and the possibility that prolonged/repeated virus shedding may be required for adequate stimulation of 7S antibody responses to gH. Natural routes of infection, however, may produce higher seroconversion rates. High gH antibody seroprevalences (~80%) were found among wild green turtles in three Florida localities with different FP prevalences, including one site with no history of FP. In addition, all 8 loggerhead turtles (Caretta caretta) tested were seropositive despite FP being uncommon in this species. The possibility that CFPHV infection may be common relative to disease suggests roles for environmental and host factors as modulators of disease expression. Alternatively, the possibility of other antigenically similar herpesviruses present in wild populations cannot be excluded, although antibody cross-reactivity with Lung, Eye, Trachea Herpesvirus (LETHV) was ruled out in this study.







Home Help [Feedback] [For Subscribers] [Archive] [Search] --
Antimicrob. Agents Chemother. Clin. Microbiol. Rev. Infect. Immun.
J. Clin. Microbiol. J. Virol. ALL ASM JOURNALS

Copyright © 2008 by the American Society for Microbiology. All rights reserved.